Nigel Robert Burns
Plus aucun poste en cours
Profil
Nigel Robert Burns is the founder of Nascient Ltd., Sweetspot Therapeutics Ltd.
He worked as a Senior Vice President at MedImmune Ltd.
and as a Non-Executive Director at Kuur Therapeutics Ltd., Navion Ltd., and Iksuda Therapeutics Ltd.
He received his undergraduate and doctorate degrees from Imperial College London.
Anciens postes connus de Nigel Robert Burns
| Sociétés | Poste | Fin |
|---|---|---|
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Président | - |
| Sweetspot Therapeutics Ltd. | Directeur Général | - |
Navion Ltd.
 Navion Ltd. Pharmaceuticals: MajorHealth Technology Navion Pharma Ltd. operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases. The company was founded in 2008 and is headquartered in London, GB. | Directeur/Membre du Conseil | - |
Nascient Ltd.
 Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Fondateur | - |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Nigel Robert Burns
| Imperial College London | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Navion Ltd.
Navion Ltd. Pharmaceuticals: MajorHealth Technology Navion Pharma Ltd. operates as a therapeutics company. It focuses on discoveries in the areas of cancer and metastatic diseases. The company was founded in 2008 and is headquartered in London, GB. | Health Technology |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Health Technology |
Nascient Ltd.
Nascient Ltd. BiotechnologyHealth Technology Nascient Ltd. develops a novel antibody treatment for rheumatoid arthritis. The company was founded by Phil Bland-Ward, Kim Midwood and Nigel Robert Burns in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
| Sweetspot Therapeutics Ltd. |